DGNOF
Price
$0.21
Change
-$0.06 (-22.22%)
Updated
Feb 3 closing price
Capitalization
21.6M
Intraday BUY SELL Signals
EBYH
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Capitalization
2.64M
Intraday BUY SELL Signals
Interact to see
Advertisement

DGNOF vs EBYH

Header iconDGNOF vs EBYH Comparison
Open Charts DGNOF vs EBYHBanner chart's image
Diagnos
Price$0.21
Change-$0.06 (-22.22%)
Volume$39.49K
Capitalization21.6M
E-Buy Home
Price$0.16
Change-$0.00 (-0.00%)
Volume$500
Capitalization2.64M
DGNOF vs EBYH Comparison Chart in %
DGNOF
Daily Signal:
Gain/Loss:
EBYH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DGNOF vs. EBYH commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGNOF is a Hold and EBYH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (DGNOF: $0.21 vs. EBYH: $0.18)
Brand notoriety: DGNOF and EBYH are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: DGNOF: 30% vs. EBYH: 33%
Market capitalization -- DGNOF: $21.6M vs. EBYH: $2.64M
DGNOF [@Services to the Health Industry] is valued at $21.6M. EBYH’s [@Services to the Health Industry] market capitalization is $2.64M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $31.36B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $1.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGNOF’s FA Score shows that 0 FA rating(s) are green whileEBYH’s FA Score has 0 green FA rating(s).

  • DGNOF’s FA Score: 0 green, 5 red.
  • EBYH’s FA Score: 0 green, 5 red.
According to our system of comparison, EBYH is a better buy in the long-term than DGNOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGNOF’s TA Score shows that 2 TA indicator(s) are bullish while EBYH’s TA Score has 4 bullish TA indicator(s).

  • DGNOF’s TA Score: 2 bullish, 7 bearish.
  • EBYH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EBYH is a better buy in the short-term than DGNOF.

Price Growth

DGNOF (@Services to the Health Industry) experienced а -5.51% price change this week, while EBYH (@Services to the Health Industry) price change was +8.84% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -6.40%. For the same industry, the average monthly price growth was -10.20%, and the average quarterly price growth was -8.80%.

Industries' Descriptions

@Services to the Health Industry (-6.40% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DGNOF($21.6M) has a higher market cap than EBYH($2.64M). EBYH YTD gains are higher at: 12.150 vs. DGNOF (-20.665). EBYH has higher annual earnings (EBITDA): -461.74K vs. DGNOF (-4.09M). EBYH has less debt than DGNOF: EBYH (38K) vs DGNOF (2.39M). DGNOF has higher revenues than EBYH: DGNOF (79K) vs EBYH (1.38K).
DGNOFEBYHDGNOF / EBYH
Capitalization21.6M2.64M817%
EBITDA-4.09M-461.74K887%
Gain YTD-20.66512.150-170%
P/E RatioN/AN/A-
Revenue79K1.38K5,712%
Total Cash737KN/A-
Total Debt2.39M38K6,284%
FUNDAMENTALS RATINGS
DGNOF vs EBYH: Fundamental Ratings
DGNOF
EBYH
OUTLOOK RATING
1..100
5097
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6350
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGNOF's Valuation (94) in the null industry is in the same range as EBYH (95). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

EBYH's Profit vs Risk Rating (90) in the null industry is in the same range as DGNOF (100). This means that EBYH’s stock grew similarly to DGNOF’s over the last 12 months.

EBYH's SMR Rating (100) in the null industry is in the same range as DGNOF (100). This means that EBYH’s stock grew similarly to DGNOF’s over the last 12 months.

EBYH's Price Growth Rating (50) in the null industry is in the same range as DGNOF (63). This means that EBYH’s stock grew similarly to DGNOF’s over the last 12 months.

EBYH's P/E Growth Rating (100) in the null industry is in the same range as DGNOF (100). This means that EBYH’s stock grew similarly to DGNOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGNOFEBYH
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
DGNOF
Daily Signal:
Gain/Loss:
EBYH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMROF0.250.03
+12.11%
AMAERO LTD.
ANZFF0.350.01
+2.83%
Air New Zealand Ltd.
ELEEF25.660.16
+0.63%
Element Fleet Mgmt Corp.
XRPN10.24N/A
N/A
Armada Acquisition Corp. II
BAYA11.85-0.02
-0.17%
Bayview Acquisition Corp

DGNOF and

Correlation & Price change

A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-1.96%
KNAMF - DGNOF
27%
Poorly correlated
N/A
NEXOY - DGNOF
23%
Poorly correlated
-1.27%
NEXOF - DGNOF
20%
Poorly correlated
N/A
EBYH - DGNOF
10%
Poorly correlated
N/A
LFMD - DGNOF
6%
Poorly correlated
-3.05%
More

EBYH and

Correlation & Price change

A.I.dvisor tells us that EBYH and FBSFF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EBYH and FBSFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBYH
1D Price
Change %
EBYH100%
N/A
FBSFF - EBYH
30%
Poorly correlated
N/A
MRT - EBYH
25%
Poorly correlated
+1.50%
LVWD - EBYH
20%
Poorly correlated
-7.14%
DGNOF - EBYH
10%
Poorly correlated
-1.96%
DNACF - EBYH
8%
Poorly correlated
N/A
More